首页> 外文期刊>Clinical neuropharmacology >Increased Frequency of Encopresis in a Child Diagnosed With Attention Deficit/Hyperactivity Disorder and Encopresis After Atomoxetine Use: A Case Report
【24h】

Increased Frequency of Encopresis in a Child Diagnosed With Attention Deficit/Hyperactivity Disorder and Encopresis After Atomoxetine Use: A Case Report

机译:诊断为注意缺陷/多动障碍和使用阿托莫西汀后遗尿症的儿童中遗尿症的频率增加:一例报告

获取原文
获取原文并翻译 | 示例
       

摘要

Attention deficit hyperactivity disorder (ADHD) is among the most frequently reported coexisting psychiatric conditions in children with encopresis. Some case reports state that atomoxetine-a selective presynaptic norepinephrine reuptake inhibitor-approved for treatment of ADHD is also effective in the treatment of coexisting encopresis. Contrasting those reports, here we present a case diagnosed with ADHD and secondary encopresis without constipation whose encopretic symptoms increased after atomoxetine treatment and discuss possible mechanisms.
机译:注意缺陷多动障碍(ADHD)是伴便秘儿童中最常报告的精神疾病。一些病例报告指出,经批准用于治疗ADHD的阿莫西汀-一种选择性的突触前去甲肾上腺素再摄取抑制剂,在共存encopresis的治疗中也有效。与这些报告相反,在此我们介绍一个诊断为ADHD和继发性便秘而无便秘的病例,其在阿托西汀治疗后其便秘症状增加,并讨论了可能的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号